Ökonomische Evaluation der Physiologischen Elektrolyttherapie bei Herzrhythmusstörungen

verfasst von

J. M. Graf, A. Uber

Abstract

Aim: The costs of physiological electrolyte therapy in cardiac rhythm problems and its benefit will be evaluated. Method: In accordance with the German recommendations/guidelines on health economic evaluations, a record of costs will be carried out for the treatment of cardiac rhythm problems with potassium and magnesium, a synthetic antiarrhythmic drug, synthetic antiarrhythmic drug and potassium/magnesium. A decision tree will be developed from the data in order to estimate the resulting costs of cardiac rhythm problems. As a further ground for discussion, the quality of life will be measured using the SF-36 and EQ-5D. Results: The treatment costs of 172 study participants totalled 621,175 DM per year, equal to approximately 3,610 DM per patient. Patients who take the electrolyte preparation generate considerably more costs (up to 3,980 DM) than those patients who do not (795 DM), as the dose resulted additionally in the classical antiarrhythmica. The decision tree analysis shows, however, that the intake of the potassium-magnesium preparation leads to a less frequent claim for cost-inducing care programmes, to the extent that after three years of treatment up to 550 DM can be saved. Conclusion: The decision tree analysis shows that a long term administration of a medicine with a potassium/magnesium preparation can reduce costs, despite the electrolyte therapy being on average 515 DM more expensive.

Organisationseinheit(en)

Institut für Gesundheitsökonomie

Typ

Artikel

Journal

Gesundheitsokonomie und Qualitatsmanagement

Band

6

Seiten

153-160

Anzahl der Seiten

8

ISSN

1432-2625

Publikationsdatum

12.2001

Publikationsstatus

Veröffentlicht

Peer-reviewed

Ja

ASJC Scopus Sachgebiete

Health policy

Ziele für nachhaltige Entwicklung

SDG 3 – Gute Gesundheit und Wohlergehen

Elektronische Version(en)

https://doi.org/10.1055/s-2001-19186 (Zugang: Geschlossen)